NCT06484023

Posterior Tibial Transcutaneous Neurostimulation in Idiopathic Overactive Bladder

Place and Efficacy of Treatment With Posterior Tibial Transcutaneous Neurostimulation in Women With Idiopathic Overactive Bladder

• Status: Completed
• Phase: —
• Study type: Observational
• Enrollment: 45 (actual)
• Sponsor: Hopital Nord Franche-Comte · Academic / Other
• Sex: Female
• Age: 18 Years
• Healthy volunteers: —

Summary

Overactive bladder is a clinical diagnosis affecting up to 17% of women. The existing medical treatment, anticholinergics, has many side effects and is sometimes ineffective. Neurostimulation of the posterior tibial nerve is a validated 3rd-line therapy, after failure of perineal re-education and medication. Studies on TENS have shown a real impact on patients quality of life and encourage its use in routine clinical practice. TENSI+ medical device is a treatment for overactive bladder. It is non-invasive, placed over the posterior tibial nerve pathway and sends electrical stimulation via electrodes located on the skin. Discreet and without side effects for users, this treatment is indicated as 3rd-line treatment for people suffering from idiopathic overactive bladder with no contraindications. The aim of this study is to assess the quality of life of patients using this device, both before use and after at least 3 months of use.

Conditions

• Overactive Bladder

Interventions

Type	Name	Description
OTHER	Survey	quality of life questionnaire

Timeline

• Start date: 2024-03-29
• Primary completion: 2024-04-26
• Completion: 2024-06-17
• First posted: 2024-07-03
• Last updated: 2024-07-03

Locations

1 site across 1 country: France